Fluofarma Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

Fluofarma General Information

Description

Provider of content analysis technologies to perform and develop cell-based assays. The company offers following services including assay development, cell-based screening, drug profiling, predictive toxicology, biomarker analysis in blood and tissues.

Contact Information

Website
www.fluofarma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 2 rue Robert Escarpit
  • 33600 Pessac
  • France
Primary Industry
Biotechnology
Other Industries
Monitoring Equipment
Laboratory Services (Healthcare)
Acquirer
Porsolt
Corporate Office
  • 2 rue Robert Escarpit
  • 33600 Pessac
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluofarma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Dec-2015 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Fluofarma’s complete valuation and funding history, request access »

Fluofarma Patents

  • 14

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Fluofarma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150131887-A1 System and method to visualize and analyze data from image-based cellular assays or high content screening Inactive 15-Apr-2011 000000000 0
FR-2900150-B1 1,4-naphthinquinone compounds, compositions comprising the same, and use thereof as anti-cancer agent Inactive 25-Apr-2006 0000000000
EP-2010481-A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents Inactive 25-Apr-2006 0000000000
US-20090247472-A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents Inactive 25-Apr-2006 0000000000
AU-2007245621-A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents Inactive 25-Apr-2006 C07C271/18
To view Fluofarma’s complete patent history, request access »

Fluofarma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fluofarma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Incubateur Régional d'Aquitaine Accelerator/Incubator 000 0000 000000 0
To view Fluofarma’s complete investors history, request access »

Ready to get started?

Request a free trial

Fluofarma FAQs

  • When was Fluofarma founded?

    Fluofarma was founded in 2003.

  • Who is the founder of Fluofarma?

    Francesca De Giorgi Ph.D, François Ichas Ph.D, and Pier Vincenzo Piazza Ph.D are the founders of Fluofarma.

  • Where is Fluofarma headquartered?

    Fluofarma is headquartered in Pessac, France.

  • What is the size of Fluofarma?

    Fluofarma has 17 total employees.

  • What industry is Fluofarma in?

    Fluofarma’s primary industry is Biotechnology.

  • Is Fluofarma a private or public company?

    Fluofarma is a Private company.

  • What is Fluofarma’s current revenue?

    The current revenue for Fluofarma is 00000.

  • Who are Fluofarma’s investors?

    Incubateur Régional d'Aquitaine has invested in Fluofarma.

  • When was Fluofarma acquired?

    Fluofarma was acquired on 10-Dec-2015.

  • Who acquired Fluofarma?

    Fluofarma was acquired by Porsolt.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »